NIOX Group PLC (NIOX) - Total Liabilities

Latest as of December 2025: GBX8.60 Million GBX ≈ $1.05K USD

Based on the latest financial reports, NIOX Group PLC (NIOX) has total liabilities worth GBX8.60 Million GBX (≈ $1.05K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

NIOX Group PLC - Total Liabilities Trend (2013–2025)

This chart illustrates how NIOX Group PLC's total liabilities have evolved over time, based on quarterly financial data. See NIOX Group PLC working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

NIOX Group PLC Competitors by Total Liabilities

The table below lists competitors of NIOX Group PLC ranked by their total liabilities.

Company Country Total Liabilities
Universal Biosensors Inc
AU:UBI
Australia AU$7.86 Million
Colabor Group Inc.
TO:GCL
Canada CA$322.31 Million
Arkadia Digital Media Tbk PT
JK:DIGI
Indonesia Rp22.23 Billion
Timah Resources Ltd
AU:TML
Australia AU$10.26 Million
Cullen Resources Ltd
AU:CUL
Australia AU$174.32K
Eguana Technologies Inc
V:EGT
Canada CA$56.29 Million
Railway Metrics & Dynamics Sweden AB
ST:RMDX
Sweden Skr44.64 Million
Damon Inc. Common Stock
NASDAQ:DMN
USA $29.17 Million

Liability Composition Analysis (2013–2025)

This chart breaks down NIOX Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NIOX Group PLC market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.81 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.12 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.11 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NIOX Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NIOX Group PLC (2013–2025)

The table below shows the annual total liabilities of NIOX Group PLC from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 GBX8.60 Million
≈ $1.05K
-3.37%
2024-12-31 GBX8.90 Million
≈ $1.08K
+15.58%
2023-12-31 GBX7.70 Million
≈ $936.87
0.00%
2023-12-30 GBX7.70 Million
≈ $936.87
-53.61%
2022-12-31 GBX16.60 Million
≈ $2.02K
0.00%
2022-12-30 GBX16.60 Million
≈ $2.02K
-15.31%
2021-12-31 GBX19.60 Million
≈ $2.38K
0.00%
2021-12-30 GBX19.60 Million
≈ $2.38K
-47.03%
2020-12-31 GBX37.00 Million
≈ $4.50K
0.00%
2020-12-30 GBX37.00 Million
≈ $4.50K
-77.16%
2019-12-31 GBX162.00 Million
≈ $19.71K
0.00%
2019-12-30 GBX162.00 Million
≈ $19.71K
+30.23%
2018-12-31 GBX124.40 Million
≈ $15.14K
0.00%
2018-12-30 GBX124.40 Million
≈ $15.14K
+303.90%
2017-12-31 GBX30.80 Million
≈ $3.75K
0.00%
2017-12-30 GBX30.80 Million
≈ $3.75K
+43.26%
2016-12-31 GBX21.50 Million
≈ $2.62K
0.00%
2016-12-30 GBX21.50 Million
≈ $2.62K
-55.49%
2015-12-31 GBX48.30 Million
≈ $5.88K
0.00%
2015-12-30 GBX48.30 Million
≈ $5.88K
+397.94%
2014-12-31 GBX9.70 Million
≈ $1.18K
0.00%
2014-12-30 GBX9.70 Million
≈ $1.18K
+21.45%
2013-12-31 GBX7.99 Million
≈ $971.79
0.00%
2013-12-30 GBX7.99 Million
≈ $971.79
--

About NIOX Group PLC

LSE:NIOX UK Medical Devices
Market Cap
$2.95 Million
GBX24.24 Billion GBX
Market Cap Rank
#29490 Global
#589 in UK
Share Price
GBX57.60
Change (1 day)
+2.13%
52-Week Range
GBX54.40 - GBX76.00
All Time High
GBX306.79
About

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide … Read more